In-hospital severe COVID-19 in a philanthropic tertiary hospital setting
is asthma a concern? A retrospective study
Palavras-chave:
Asthma, COVID-19, SARS-CoV-2, Hospitalization, DeathResumo
BACKGROUND: The frequency of coronavirus disease 2019 (COVID-19) cases among asthmatics has been reported to be reduced. However, the findings regarding the association between asthma and the risk of severe COVID-19 have been divergent. OBJECTIVE: To investigate whether asthma is associated with a reduced risk of development of severe COVID-19. DESIGN AND SETTING: Retrospective analysis on COVID-19 surveillance databases at two tertiary-level hospitals in São Paulo, Brazil. METHODS: The medical records of patients hospitalized due to COVID-19 between March and August 2020 were reviewed in accordance with the clinical, laboratorial, radiological and epidemiological criteria for COVID-19, and for comorbidities. RESULTS: Among the adult patients included (> 18 years of age) there were 52 asthmatics and 1,318 non-asthmatics. Their median ages and interquartile ranges (IQR) were, respectively, 54 (41-69) and 60 (44-72) years. At least one comorbidity was seen in 73% of asthmatics and 56% of the non-asthmatics. Among the asthmatics, most presented mild asthma (92%) and the prevalence of chronic obstructive pulmonary disease (COPD) was high (27%). The asthmatics presented an unadjusted odds ratio (OR) for severe COVID-19 of 0.89 (95% confidence interval, CI 0.5-1.56); and OR 0.88 (95% CI 0.5 -1.68) after multivariable adjustment. Age > 60 years, male sex, hypertension, diabetes, cancer and homelessness were covariates associated with increased odds for severe COVID-19. Kaplan-Meier estimated survival over hospitalization of up to 30 days did not differ between the groups (log-rank P = 0.09). CONCLUSIONS: The association between asthma and decreased risk of severe COVID-19 or increased survival was statistically non-significant.
Downloads
Referências
Green I, Merzon E, Vinker S, Golan-Cohen A, Magen E. COVID-19 Susceptibility in Bronchial Asthma. J Allergy Clin Immunol Pract. 2021;9(2):684-692.e1. PMID: 33242628; https://doi.org/10.1016/j.jaip.2020.11.020.
Caminati M, Vultaggio A, Matucci A, et al. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021;176:106261. PMID: 33260107; https://doi.org/10.1016/j.rmed.2020.106261.
Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909-23. PMID: 33812494; https://doi.org/10.1016/S2213-2600(21)00095-3.
Peters MC, Sajuthi S, Deford P, et al. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. Am J Respir Crit Care Med. 2020;202(1):83-90. PMID: 32348692; https://doi.org/10.1164/rccm.202003-0821OC. Erratum in: Am J Respir Crit Care Med. 2020;202(12):1744-46.
Camiolo M, Gauthier M, Kaminski N, Ray A, Wenzel SE. Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype. J Allergy Clin Immunol. 2020;146(2):315-324.e7. PMID: 32531372; https://doi.org/10.1016/j.jaci.2020.05.051.
Finney LJ, Glanville N, Farne H, et al. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. J Allergy Clin Immunol. 2021;147(2):510-519.e5. PMID: 33068560; https://doi.org/10.1016/j.jaci.2020.09.034.
Centers for Disease Control and Prevention, CDC. National Notifiable Diseases Surveillance System (NNDSS). Available from: https://ndc.services.cdc.gov/ Accessed in 2021 (Dec 15).
Simpson S, Kay FU, Abbara S, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication. J Thorac Imaging. 2020;35(4):219-27. PMID: 32324653; https://doi.org/10.1097/RTI.0000000000000524.
Global Initiative for Asthma. 2021 GINA Report, Global Strategy for Asthma Management and Prevention. Available from: https://ginasthma.org/gina-reports/ Accessed in 2021 (Dec 16).
Safiri S, Carson-Chahhoud K, Karamzad N, et al. Prevalence, deaths and disability-adjusted-life-years (DALYs) due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019. Chest. 2021:S0012-3692(21)04206-9. PMID: 34699773; https://doi.org/10.1016/j.chest.2021.09.042.
Caminati M, Vultaggio A, Matucci A, et al. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021;176:106261. PMID: 33260107; https://doi.org/10.1016/j.rmed.2020.106261.
Caruso C, Colantuono S, Urbani S, et al. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy. Expert Rev Respir Med. 2021;15(8):1057-60. PMID: 33896350; https://doi.org/10.1080/17476348.2021.1917387.
Hawkins RB, Charles EJ, Mehaffey JH. Socio-economic status and COVID-19-related cases and fatalities. Public Health. 2020;189:129-34. PMID: 33227595; https://doi.org/10.1016/j.puhe.2020.09.016.
Curto E, Crespo-Lessmann A, González-Gutiérrez MV, et al. Is asthma in the elderly different? Functional and clinical characteristics of asthma in individuals aged 65 years and older. Asthma Res Pract. 2019;5:2. PMID: 30937177; https://doi.org/10.1186/s40733-019-0049-x.
Ulambayar B, Lee SH, Yang EM, Ye YM, Park HS. Association Between Epithelial Cytokines and Clinical Phenotypes of Elderly Asthma. Allergy Asthma Immunol Res. 2019;11(1):79-89. PMID: 30479079; https://doi.org/10.4168/aair.2019.11.1.79.
Asch DA, Sheils NE, Islam MN, et al. Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic. JAMA Intern Med. 2021;181(4):471-8. PMID: 33351068; https://doi.org/10.1001/jamainternmed.2020.8193.
Gülsen A, König IR, Jappe U, Drömann D. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis. Respirology. 2021;26(6):552-65. PMID: 33955623; https://doi.org/10.1111/resp.14049.
Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis. Eur Respir J. 2021:2101209. PMID: 34385278; https://doi.org/10.1183/13993003.01209-2021.
Zhu Z, Hasegawa K, Ma B, et al. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146(2):327-329.e4. PMID: 32522462; https://doi.org/10.1016/j.jaci.2020.06.001.
Putcha N, Fawzy A, Matsui EC, et al. Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene. Chest. 2020;158(6):2333-45. PMID: 32450244; https://doi.org/10.1016/j.chest.2020.04.069.
Matusiak M, Schürch CM. Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics. Respir Res. 2020;21(1):252. PMID: 32993656; https://doi.org/10.1186/s12931-020-01521-x.
Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203-206.e3. PMID: 32333915; https://doi.org/10.1016/j.jaci.2020.04.009.
Wark PAB, Pathinayake PS, Kaiko G, et al. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma. Respirology. 2021;26(5):442-51. PMID: 33455043; https://doi.org/10.1111/resp.14003.
Milne S, Li X, Yang CX, et al. Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial. Eur Respir J. 2021;58(1):2100130. PMID: 33795322; https://doi.org/10.1183/13993003.00130-2021.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
